Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Where is Asia's Biopharma Industry Heading in 2016 and Beyond? 2016-03-16 09:15
Prenetics Raises US$10M Strategic Investment Led by Ping An 2016-03-16 09:00
BETADINE(R) Leads the Fight Against Hand Foot and Mouth Disease (HFMD) Infection 2016-03-15 11:03
Specialized Therapeutics Grants Sublicense for Anti-Emetic Products to Mundipharma for Australia and New Zealand 2016-03-08 11:29
Celsion Corporation Announces Launch of the OPTIMA Study in China 2016-03-07 21:00
Major Liver Cancer Study Completes Palliative Cohort Enrolment 2016-03-07 20:37
3SBio's PEG-irinotecan Wins IND Approval From China FDA 2016-03-07 17:24
Singapore-based Asian American Medical Group Opens Myanmar's First Dedicated Gastrointestinal & Liver Centre in Collaboration with Pinlon Hospital and 30th Street Clinic 2016-03-07 09:30
Debiopharm International SA Has Won Its Patent Infringement Suit for Elplat(R) Against Nippon Kayaku Co., Ltd. 2016-03-04 07:00
HSRx Biopharmaceutical and Thorne Research in Collaboration for Botanical Drug Development 2016-03-03 23:00
Nanotechnology Accelerates the Evolution of Precision Medicine, Finds Frost & Sullivan 2016-03-02 03:28
Pharma Indonesia and India: A Stronger Partnership In The Making 2016-03-01 14:09
JHL Biotech and Affinita Biotech Agree to Partner in the Development and Manufacturing of Oncology Monoclonal Antibodies 2016-03-01 07:45
Sihuan Pharmaceutical Meets all Conditions for Resumption of Trading 2016-02-27 00:49
Knee Osteoarthritis: Autologous Conditioned Serum (ACS) Combined with Physiotherapy Led to Significant Improvement in Pain and Function 2016-02-25 09:00
ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir 2016-02-25 01:34
ViiV Healthcare Announces Phase II Study Results for First Two Drug, Long-acting Injectable Regimen for HIV-1 Treatment 2016-02-24 04:03
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 2 Infection 2016-02-23 11:08
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 1 Infection 2016-02-23 11:04
Aptuit and Icagen Agree to Strategic Alliance 2016-02-22 22:00
1 391 392 393 394 395 412